Markets remained unsettled in March by the rise in US Treasury yields and concurrent rise in inflation expectations. This has broad implications across equity, bond and commodity markets. With much of the developed world sovereign debt market yielding below zero in real terms…
After an eventful 2020, the New Year began with several major changes. Joseph Biden was inaugurated as the 46th President of the United States amid protests in Washington. Britain officially left the European Union transition period and trade began on…
December saw a resurgence in coronavirus disruption worldwide, leading governments to impose travel restrictions and lockdowns. A new variant of the virus was detected in the UK, prompting European countries to restrict travel to and from the country. Meanwhile, the…
November was an eventful month for capital markets. Joseph Biden won the US Presidential election, and there were breakthrough trial results of Covid-19 vaccinations from Pfizer/BioNTech and Moderna, which both recorded over 90% effectiveness. Equity markets rallied globally, with the…
Coronavirus cases continued to rise globally in October, and several countries saw a return of lockdown measures aimed at containing the virus. Political events continue to influence markets and macroeconomic developments, as epidemiological changes force governments around the world to…
The global equity market rally that had powered stocks into positive year to date territory lost steam in September. The MSCI World ended the month down 0.05% in September and 4.22% on the year. A resurgence in Coronavirus cases across…
Global stocks recorded their largest August gain since 1986. Apple became the first US listed company to reach a $2tn market capitalization. The VIX index, which measures volatility, fell to its lowest level since March. However, there remains significant uncertainty…
In February, optimism surrounding the global vaccine rollout and renewed inflation expectations combined to drive up bond yields and cyclical stocks. This came at the expense of previously favoured growth equities, some of which suffered their worst month since last…